Concepedia

Identification and Characterization of NDT 9513727 [N,N-bis(1,3-Benzodioxol-5-ylmethyl)-1-butyl-2,4-diphenyl-1 H-imidazole-5-methanamine], a Novel, Orally Bioavailable C5a Receptor Inverse Agonist

Robbin Brodbeck, Daniel N. Cortright, Andrzej Kieltyka, Jianying Yu, Carolyn Baltazar, Marianne E. Buck, Robin Meade, George D. Maynard, Andrew Thurkauf, Du‐Shieng Chien,

Journal of Pharmacology and Experimental Therapeutics · 2008 · 30 citations · 24 references

DOI

Concepts

References

24

SOME QUANTITATIVE USES OF DRUG ANTAGONISTS

O. ARUNLAKSHANA, H. O. Schild · British Journal of Pharmacology and Chemotherapy · 1959 · 4K citations · Full text

, , +16

Arthritis Critically Dependent on Innate Immune System Players

Hong Ji, Koichiro Ohmura, Umar Mahmood et al. · Immunity · 2002 · 694 citations · Full text

, , +14

The chemotactic receptor for human C5a anaphylatoxin

Norma P. Gerard, Craig Gérard · Nature · 1991 · 659 citations

, , +12

Drusen complement components C3a and C5a promote choroidal neovascularization

Miho Nozaki, Brian J. Raisler, Eiji Sakurai et al. · Proceedings of the National Academy of Sciences · 2006 · 651 citations · Full text

, , +12

Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease.

Yijun Wang, Scott A. Rollins, Joseph A. Madri et al. · Proceedings of the National Academy of Sciences · 1995 · 356 citations

, , +17